Format

Send to

Choose Destination
Blood. 2012 Aug 16;120(7):1422-31. doi: 10.1182/blood-2012-03-419747. Epub 2012 Jul 11.

Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells.

Author information

1
Washington University School of Medicine, 660 S Euclid Ave, St Louis, MO 63110, USA.

Abstract

TLR agonists initiate a rapid activation program in dendritic cells (DCs) that requires support from metabolic and bioenergetic resources. We found previously that TLR signaling promotes aerobic glycolysis and a decline in oxidative phosphorylation (OXHPOS) and that glucose restriction prevents activation and leads to premature cell death. However, it remained unclear why the decrease in OXPHOS occurs under these circumstances. Using real-time metabolic flux analysis, in the present study, we show that mitochondrial activity is lost progressively after activation by TLR agonists in inflammatory blood monocyte-derived DCs that express inducible NO synthase. We found that this is because of inhibition of OXPHOS by NO and that the switch to glycolysis is a survival response that serves to maintain ATP levels when OXPHOS is inhibited. Our data identify NO as a profound metabolic regulator in inflammatory monocyte-derived DCs.

PMID:
22786879
PMCID:
PMC3423780
DOI:
10.1182/blood-2012-03-419747
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center